A novel DYRK1A (Dual specificity tyrosine phosphorylation‐regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro

Publisher: John Wiley & Sons Inc

E-ISSN: 1471-4159|133|3|440-451

ISSN: 0022-3042

Source: JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol.133, Iss.3, 2015-05, pp. : 440-451

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract